BRÈVE

sur G&L Healthcare Advisors

Regulatory Expert Appointed to Lead West Coast US Client Engagement for G&L Healthcare Advisors

MADISON, NJ / ACCESSWIRE / June 3, 2024 - G&L Healthcare Advisors has announced the appointment of Richard Edmunds, a veteran with 25 years in regulatory affairs, to lead their U.S. West Coast business expansion from their San Diego office.

Edmunds brings extensive expertise in regulatory and clinical development, partnering with biotech and pharmaceutical clients to expedite drug development and product launches. He has aided over 50 companies in securing regulatory approval.

Richard's expertise combines technical and business acumen, assisting clients from proof-of-concept studies to global expansion and post-approval activities.

Dave Yungvirt, G&L's COO, stated, "We are excited that Richard has agreed to help take G&L to the next level, serving our West Coast clients to ultimately meet patient needs."

R. H.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de G&L Healthcare Advisors